ITGB1 and neoplasm: The immunoblots of cells, as well as immunohistochemistry (IHC) of tumor xenografts, consistently demonstrated an increased expression of the heterophilic adhesion molecule integrin β1 (ITGB1) in metastatic tumors compared to non-metastatic tumors (Figures 4b and c).